Gene therapy could restore saliva for cancer survivors
Disease control
Recruiting now
This study is testing whether a gene therapy called AAV2-hAQP1 can help people who have severe, long-term dry mouth after radiation treatment for head or neck cancer. Researchers will inject the therapy directly into the salivary glands of 276 participants to see if it safely inc…
Phase: PHASE2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC